Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Operates in Healthcare Services — Other healthcare services. Per the activity note to the FY2024 annual report, the company provides medical services. Headquarters in Senaki with main office in Tbilisi; founded by Ivieta Gviniashvili and Ltd Sena-Medi.
| Ratio | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Margins | |||||
| Gross Margin | 80.9% | 73.3% | 78.5% | 84.8% | 89.8% |
| EBITDA Margin | 8.2% | 34.7% | 9.3% | 2.4% | 12.9% |
| EBITDAR | 95 | 802 | 162 | 49 | 181 |
| EBITDAR Margin | 8.2% | 34.7% | 10.9% | 4.7% | 14.8% |
| EBIT Margin | 2.7% | 30.6% | 5.6% | -4.1% | 8.3% |
| Net Profit Margin | 0.5% | 34.8% | 5.1% | -4.1% | 6.3% |
| Operating Expense % of Sales | 72.7% | 38.6% | 69.2% | 82.4% | 76.9% |
| Returns | |||||
| Return on Assets (ROA) | 0.6% | 44.8% | 4.6% | -2.6% | 4.2% |
| Return on Equity (ROE) | 0.6% | 52.1% | 5.1% | -2.9% | 5.1% |
| ROIC [EBIT / Invested Capital] | 3.7% | 50.9% | 5.7% | -3.0% | 7.0% |
| Leverage & debt balances | |||||
| Debt-to-Assets | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Debt-to-Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Debt-to-EBITDA | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Equity-to-Assets | 97.1% | 85.9% | 90.8% | 87.9% | 83.3% |
| Net Debt | -72 | -154 | -17 | -18 | -72 |
| Cash & Equivalents | 72 | 154 | 17 | 18 | 72 |
| Total Debt | N/A | N/A | N/A | N/A | N/A |
| Liquidity & working capital | |||||
| Current Ratio | 11.16x | 3.87x | 6.62x | 6.75x | 6.60x |
| Quick Ratio | 10.34x | 3.62x | 6.62x | 6.75x | 6.60x |
| Cash Ratio | 3.26x | 0.61x | 0.11x | 0.12x | 0.43x |
| Total Current Assets | 246 | 984 | 1,003 | 1,029 | 1,107 |
| Total Current Liabilities | 22 | 254 | 151 | 152 | 168 |
| Inventory | 18 | 64 | N/A | N/A | N/A |
| Trade Receivables | 137 | 701 | 779 | 834 | 951 |
| Trade Payables | 22 | 254 | 104 | 152 | 168 |
| Net Working Capital | 224 | 730 | 852 | 876 | 939 |
| Net Working Capital % of Revenue | 19.3% | 31.6% | 57.4% | 84.9% | 76.9% |
| Trade Working Capital | 134 | 512 | 675 | 682 | 783 |
| Trade Working Capital % of Revenue | 11.5% | 22.1% | 45.5% | 66.1% | 64.1% |
| Change in Trade Working Capital | N/A | 378 | 164 | 6 | 101 |
| Turnover & efficiency | |||||
| Inventory Turnover | 12.16x | 9.59x | N/A | N/A | N/A |
| Days Inventory Outstanding (DIO) | 30.0 | 38.1 | N/A | N/A | N/A |
| Receivables Turnover | 8.44x | 3.30x | 1.90x | 1.24x | 1.28x |
| Days Sales Outstanding (DSO) | 43.2 | 110.7 | 191.8 | 295.0 | 284.1 |
| Payables Turnover | 10.05x | 2.43x | 3.07x | 1.03x | 0.74x |
| Days Payable Outstanding (DPO) | 36.3 | 150.1 | 118.9 | 354.3 | 491.9 |
| Cash Conversion Cycle | 36.9 days | -1.3 days | 72.9 days | -59.3 days | -207.8 days |
| Asset Turnover | 1.24x | 1.29x | 0.91x | 0.63x | 0.67x |
| Cash flow & dividends | |||||
| Operating Cash Flow | 17 | 83 | 505 | 2 | 53 |
| Free Cash Flow (OCF − Capex proxy) | 17 | 83 | -138 | 2 | 53 |
| Cash Conversion (OCF / EBITDA) | 18.0% | 10.3% | 366.8% | 7.4% | 33.9% |
| Dividends Declared | N/A | N/A | N/A | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A | N/A | N/A | N/A |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in GEL, thousands. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →